Statement of
Target Audience
Educational Need
This educational activity will meet the
Nurses play a pivotal role in the prevention,
educational needs of oncology nurses who
diagnosis, and management of treatment
care for patients with multiple myeloma.
associated toxicities with novel therapeutics.
ONS Disclaimer
However, the current level of understanding
Meeting space has been assigned to provide a satellite symposium
and involvement varies among nurses.
funded by Celgene Corporation, Millennium Pharmaceuticals, and
the, International Myeloma Foundation via an educational grant during
Treatment associated toxicities including
the Oncology Nursing Society's (ONS) 32nd Annual Congress,
myelosuppression, peripheral neuropathy,
April 24-27, 2007 in Las Vegas, Nevada. The Oncology Nursing
Society's assignment of meeting space does not imply product
and DVT adversely impact patients with
endorsement nor does the Oncology Nursing Society assume any
multiple myeloma.
responsibility for the educational content.
This symposium addresses nursing
issues along the continuum of side effects
management from prevention to palliation.
Clinical practices that optimize quality care
and patient outcomes using science-based
evidence will be presented.
FIRST CLASS MAIL
U.S. POSTAGE
PAID
E. HANOVER, NJ
PERMIT NO. 5
55 Madison Avenue
Suite 400
Morristown, NJ 07960
Symposium Registration
Management of Novel
Therapeutics' Side Effects:
A Nurse Centric Model
Thursday
April 26, 2007
Mandalay Bay Convention Center
South Pacific Ballroom E
Las Vegas, Nevada
Program & Breakfast
6 :15 am ­ 8 :15 am
A symposium held at the
Oncology Nursing Society
32nd Annual Congress
International Myeloma Foundation
International
Nurse Leadership Board
Myeloma Foundation

---

Chair
International Myeloma
Patricia Mangan, APRN, BC
Foundation
Abramson Cancer Center
Nurse Leadership Board
University of Pennsylvania
The faculty for this symposium are
Philadelphia, Pennsylvania
members of the IMF Nurse Leadership
Board. The Board's purpose and vision
Faculty
is to foster a partnership with multiple
Teresa Miceli, RN, BSN
myeloma nurses to identify and address
Mayo Clinic
their unmet needs as well as those of
Rochester, Minnesota
their patients.
Sandra Rome, RN, MN, AOCN
CMEFirstTM plans and implements
Cedars-Sinai Medical Center
continuing-education activities that are
Los Angeles, California
fair, balanced, evidence based, evaluated
Joseph D. Tariman, RN/APN, ARPN, BC
for bias, and in the best interest of the
University of Washington
public. Faculty disclosure statements will
Seattle, Washington
be included in handout materials provided
at the activity.
Program Format
CE Credit
This activity is designed to be a didactic
Medical Education Resources is an
lecture with an interactive question-and-
approved provider of continuing nursing
answer period.
education by the Colorado Nurses
Association, an accredited approver by the
Learning Objectives
American Nurses Credentialing Center's
At the conclusion of this program,
Commission on Accreditation.
participants will be able to:
This CE activity provides 2.0 contact hours.
· Describe the currently available novel
Provider approval expires July 31, 2007.
multiple myeloma therapies
Provider approved by the California
· Discuss critical issues in nursing
Board of Registered Nursing, Provider
management and medical implications
#CEP 12299, for 2.0 contact hours.
of side effects associated with
Commercial Support
multiple myeloma therapeutic agents
This symposium is supported by the
· Identify strategies for improving the
International Myeloma Foundation.
quality of care and outcomes for patients
Grant funding is provided by Celgene
by effective management of side effects
Corporation and Millennium
Pharmaceuticals Inc.
Registration Form
First Name___________________________________
To reserve your place for Management
Last Name___________________________________
of Novel Therapeutics' Side Effects:
Degree(s)____________________________________
A Nurse Centric Model, please
complete the following information,
Title/Position_________________________________
and register via fax (269) 327-3688 or
Specialty_____________________________________
on-line at www.imfatons.com,
password ONS.
Affiliation_____________________________________
There is no registration fee for attending
Preferred Address_____________________________
this program. Please note space is
City_________________________________________
limited; we suggest that you register
as soon as possible!
State_____________ Zip_______________________
For more information, please contact
Telephone____________________________________
CMEFirst at (973) 387-5539 x-706
Fax__________________________________________
This registration form may be copied for
Email _______________________________________
your colleagues. If registering on-line,
you will receive an email confirmation
Special Needs or Requests_____________________
immediately following your on-line
____________________________________________
registration, if registering via fax, you will
receive a confirmation within 24 hours.
(ADA accommodations will be made in accordance with
the law. If you require ADA accommodations, please
indicate your need at the time of registration.)

---